Heart Disease and Stroke Statistics—2012 Update
A Report From the American Heart Association
This article has a correction. Please see:
Jump to
- Article
- Table of Contents
- Summary
- Acknowledgments
- Disclosures
- 1. About These Statistics
- 2. American Heart Association's 2020 Impact Goals
- 3. Cardiovascular Diseases
- 4. Subclinical Atherosclerosis
- 5. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris
- 6. Stroke (Cerebrovascular Disease)
- 7. High Blood Pressure
- 8. Congenital Cardiovascular Defects
- 9. Cardiomyopathy and Heart Failure
- 10. Disorders of Heart Rhythm
- 11. Other Cardiovascular Diseases
- 12. Risk Factor: Family History and Genetics
- 13. Risk Factor: Smoking/Tobacco Use
- 14. Risk Factor: High Blood Cholesterol and Other Lipids
- 15. Risk Factor: Physical Inactivity
- 16. Risk Factor: Overweight and Obesity
- Prevalence
- 17. Risk Factor: Diabetes Mellitus
- 18. End-Stage Renal Disease and Chronic Kidney Disease
- 19. Metabolic Syndrome
- 20. Nutrition
- 21. Quality of Care
- 22. Medical Procedures
- 23. Economic Cost of Cardiovascular Disease
- 24. At-a-Glance Summary Tables
- 25. Glossary
- Footnotes
- Figures & Tables
- Supplemental Materials
- Info & Metrics
- eLetters

Table of Contents
Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e3
About These Statistics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .e7
American Heart Association's 2020 Impact Goals. . . . . . . . . . . . . . . . .e10
Cardiovascular Diseases . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . .e21
Subclinical Atherosclerosis . . . . . . . . . . . . . . . . . . . . .e45
Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris . . . . . . . . .e54
Stroke (Cerebrovascular Disease) . . . . . . . . . . . . . . . . . . . . . . . . . . . .e68
High Blood Pressure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . .e88
Congenital Cardiovascular Defects . . . . . . . . . . . . . . . . . . . . . . . . . . . .e97
Cardiomyopathy and Heart Failure . . . . . . . . . . . . . . . . . . . . . . . . . . . .e102
Disorders …
This Issue
Jump to
- Article
- Table of Contents
- Summary
- Acknowledgments
- Disclosures
- 1. About These Statistics
- 2. American Heart Association's 2020 Impact Goals
- 3. Cardiovascular Diseases
- 4. Subclinical Atherosclerosis
- 5. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris
- 6. Stroke (Cerebrovascular Disease)
- 7. High Blood Pressure
- 8. Congenital Cardiovascular Defects
- 9. Cardiomyopathy and Heart Failure
- 10. Disorders of Heart Rhythm
- 11. Other Cardiovascular Diseases
- 12. Risk Factor: Family History and Genetics
- 13. Risk Factor: Smoking/Tobacco Use
- 14. Risk Factor: High Blood Cholesterol and Other Lipids
- 15. Risk Factor: Physical Inactivity
- 16. Risk Factor: Overweight and Obesity
- Prevalence
- 17. Risk Factor: Diabetes Mellitus
- 18. End-Stage Renal Disease and Chronic Kidney Disease
- 19. Metabolic Syndrome
- 20. Nutrition
- 21. Quality of Care
- 22. Medical Procedures
- 23. Economic Cost of Cardiovascular Disease
- 24. At-a-Glance Summary Tables
- 25. Glossary
- Footnotes
- Figures & Tables
- Supplemental Materials
- Info & Metrics
Article Tools
- Heart Disease and Stroke Statistics—2012 UpdateWriting Group Members, Véronique L. Roger, Alan S. Go, Donald M. Lloyd-Jones, Emelia J. Benjamin, Jarett D. Berry, William B. Borden, Dawn M. Bravata, Shifan Dai, Earl S. Ford, Caroline S. Fox, Heather J. Fullerton, Cathleen Gillespie, Susan M. Hailpern, John A. Heit, Virginia J. Howard, Brett M. Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, Diane M. Makuc, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Claudia S. Moy, Dariush Mozaffarian, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Elsayed Z. Soliman, Paul D. Sorlie, Nona Sotoodehnia, Tanya N. Turan, Salim S. Virani, Nathan D. Wong, Daniel Woo and Melanie B. Turner on behalf of the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation. 2012;125:e2-e220, originally published January 3, 2012https://doi.org/10.1161/CIR.0b013e31823ac046
Citation Manager Formats
Share this Article
- Heart Disease and Stroke Statistics—2012 UpdateWriting Group Members, Véronique L. Roger, Alan S. Go, Donald M. Lloyd-Jones, Emelia J. Benjamin, Jarett D. Berry, William B. Borden, Dawn M. Bravata, Shifan Dai, Earl S. Ford, Caroline S. Fox, Heather J. Fullerton, Cathleen Gillespie, Susan M. Hailpern, John A. Heit, Virginia J. Howard, Brett M. Kissela, Steven J. Kittner, Daniel T. Lackland, Judith H. Lichtman, Lynda D. Lisabeth, Diane M. Makuc, Gregory M. Marcus, Ariane Marelli, David B. Matchar, Claudia S. Moy, Dariush Mozaffarian, Michael E. Mussolino, Graham Nichol, Nina P. Paynter, Elsayed Z. Soliman, Paul D. Sorlie, Nona Sotoodehnia, Tanya N. Turan, Salim S. Virani, Nathan D. Wong, Daniel Woo and Melanie B. Turner on behalf of the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation. 2012;125:e2-e220, originally published January 3, 2012https://doi.org/10.1161/CIR.0b013e31823ac046